Page 288 - SAMRC Annual Report 2023-24
P. 288
ANNUAL FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024
NOTES TO THE ANNUAL FINANCIAL STATEMENTS
(CONTINUED)
31 MARCH 31 MARCH
2024 2023
R R
33. Cash generated from (used in) operations
(Deficit) surplus (21,366,607) 7,545,129
Adjustments for:
Depreciation and amortisation 32,649,514 26,087,381
Loss on sale of assets 3,621,990 2,488,740
(Gain) Loss on foreign exchange (1,162,965) (8,458,753)
Fair value adjustments (211,431) 367,464
Impairment loss/reversal of impairments on intangible assets and
property, plant and equipment 1,235,223 (1,251,843)
Debt impairment (136,828) 356,428
Movements in retirement benefit assets and liabilities (2,081,000) (2,428,000)
Movements in provisions 9,945,331 422,301
Capitalisation of financial assets (191,740) (226,021)
Non-cash adjustment on biological assets – 25,000
Non-cash adjustment on living resources (146,531) (157,209)
Other non-cash items: Donation in kind (20,622,547) –
Other non-cash items: asset replacement (2,010,452) –
Other non-cash items: property, plant and equipment 3,634,725 –
Changes in working capital:
Receivables from exchange transactions 27,653,989 (60,837,963)
Receivables from non-exchange transactions (3,538,369) (2,387,079)
Prepayments (4,351,391) 1,518,195
Payables from exchange transactions (55,028,604) 10,010,946
VAT (9,231,214) 3,776,553
Deferred income (100,995,378) 99,129,843
(142,334,285) 75,981,112
286 SAMRC ANNUAL REPOR T 2023-24